COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,042 Articles (22,627 medRxiv, 8,415 bioRxiv)

Most recent first Previous |  Page 2216: Articles 22151-22160  | Next

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitro
Xiao, T., Lu, J., Zhang, J., Johnson, R. I., McKay, L. G. A., Storm, N., Lavine, C. L., Peng, H., Cai, Y., Rits-Volloch, S., Lu, S., Quinlan, B. D., Farzan, M., Seaman, M. S., Griffiths, A., Chen, B.
10.1101/2020.09.18.301952 — Posted: 2020-09-18
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells
Nguyenla, X., Wehri, E., Van Dis, E., Biering, S., Yamashiro, L. H., Stroumza, J., Dugast-Darzacq, C., Graham, T., Stanley, S., Schaletzky, J.
10.1101/2020.09.18.302398 — Posted: 2020-09-18
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
Bolouri, H., Speake, C., Skibinski, D., Long, S. A., Hocking, A. M., Campbell, D. J., Hamerman, J. A., Malhotra, U., Buckner, J. H., BRI COVID-19 Research Team
10.1101/2020.09.18.303420 — Posted: 2020-09-18
The Peak of COVID-19 in India
Yadav, S., YADAV, P. K.
10.1101/2020.09.17.20197087 — Posted: 2020-09-18
Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care
Haroon, S., Subramanian, A., Cooper, J., Anand, A., Gokhale, K., Byne, N., Dhalla, S., Acosta-Mena, D., Taverner, T., Okoth, K., Wang, J., Chandan, J. S., Sainsbury, C., Zemedikun, D. T., Thomas, G. N., Parekh, D., Marshall, T., Sapey, E., Adderley, N. J., Nirantharakumar, K.
10.1101/2020.09.17.20196469 — Posted: 2020-09-18
Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial
Balcells, M. E., Rojas, L., Le Corre, N., Martinez-Valdebenito, C., Ceballos, M. E., Ferres, M., Chang, M., Vizcaya, C., Mondaca, S., Huete, A., Castro, R., Sarmiento, M., Villarroel, L., Pizarro, A., Ross, P., Santander, J., Lara, B., Ferrada, M., Vargas-Salas, S., Beltran-Pavez, C., Soto-Rifo, R., Valiente-Echeverria, F., Caglevic, C., Mahave, M., Selman, C., Gazitua, R., Briones, J. L., Villarroel-Espindola, F., Balmaceda, C., Espinoza, M. A., Pereira, J., Nervi, B.
10.1101/2020.09.17.20196212 — Posted: 2020-09-18
RPA-Based Method For The Detection Of SARS-CoV2
Nassir, A. A., Baptiste, M. J., Mwikarago, I., Habimana, M. R., Ndinkabandi, J., Murangwa, A., Nyatanyi, T., Muvunyi, C. M., Nsanzimana, S., Leon, M., Musanabaganwa, C.
10.1101/2020.09.17.20196402 — Posted: 2020-09-18
Seroprevalence of SARS-CoV-2 among adults in three regions of France following the lockdown and associated risk factors: a multicohort study.
Carrat, F., de Lamballerie, X., Rahib, D., Blanche, H., Lapidus, N., Artaud, F., Kab, S., Renuy, A., Szabo de Edelenyi, F., Meyer, L., Lydie, N., Charles, M.-A., Ancel, P.-Y., Jusot, F., Rouquette, A., Priet, S., Saba Villaroel, P. M., Fourie, T., Lusivika-Nzinga, C., Nicol, J., Legot, S., Druesne-Pecollo, N., Essedik, Y., Lai, C., Gagliolo, J.-M., Deleuze, J.-F., Bajos, N., Severi, G., Touvier, M., Zins, M.
10.1101/2020.09.16.20195693 — Posted: 2020-09-18
Association between corticosteroids and intubation or death among patients with COVID-19 pneumonia in non-ICU settings: an observational study using of real-world data from 51 hospitals in France and Luxembourg
Tran, V.-T., Mahevas, M., Bani Sadr, F., Robineau, O., Perpoint, T., Perrodeau, E., Gallay, L., Ravaud, P., Goehringer, F., Lescure, X., COCORICO
10.1101/2020.09.16.20195750 — Posted: 2020-09-18
How do the general population behave with facemasks to prevent COVID-19 in the community?
DESCHANVRES, C., HAUDEBOURG, T., PEIFFER-SMADJA, N., BLANCKAERT, K., BOUTOILLE, D., LUCET, J.-C., BIRGAND, G.
10.1101/2020.09.18.20195669 — Posted: 2020-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).